HIV and COVID-19 – What We’ve Learned

Host Paul Sax, MD, FIDSA, and guest Rebeca Plank, MD, MPH, return for another Let’s Talk ID draft, this time, sharing infectious diseases “love/hates.” They discuss the tools, tests and clinical strategies that inspire both enthusiasm and hesitation in everyday ID practice, and w ...  Show more

Host Buddy Creech, MD, MPH, FPIDS, is joined by pediatric infectious diseases fellows to explore what it takes to be an effective vaccine advocate, from patient conversations to policymaking. They discuss the importance of clear communication, building trust, and advancing polici ...  Show more

When HIV was first identified in the early 1980s, it was a public health crisis mired in urgent scientific questions: How was it transmitted? What were the symptoms? Could it be treated? But alongside that, and equally challenging to public health, was the stigma attached to t ...

Dr Lucy Dorrell tells us how our immune system controls HIV and how we can live with this virus. There are currently around 91,000 people in the UK living with HIV/AIDS. HIV is a challenging target for a vaccine because it can mutate its genetic makeup. Dr Lucy Dorrell aims to de ...  Show more

Humanes Immundefizienzvirus: Zwischen verpassten Diagnosen und Lichtblicken in der Forschung. 

Drs Michael S. Saag and Monica Gandhi discuss COVID-19 and the impact this pandemic has had on patients diagnosed with HIV, including vaccines, boosters, and patients who are older or have chronic comorbid conditions. Relevant disclosures can be found with the episode show notes ...  Show more